{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:58:59Z","timestamp":1790798339662,"version":"4.1.0"},"reference-count":54,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["31870080"],"award-info":[{"award-number":["31870080"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Anhui Provincial Department of Education","award":["2022AH040231"],"award-info":[{"award-number":["2022AH040231"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>The appearance of antibiotic-resistant strains of Helicobacter pylori (H. pylori) is leading to a decreased eradication rate of H. pylori infection. There is an urgent need to find new agents with antimicrobial mechanisms different from those of antibiotics, with therapeutic potential to clear colonization of H. pylori in the stomach. Some antimicrobial peptides (AMPs) possess bactericidal activity by enhancing the permeability of the outer membrane and damaging the integrity of the cell membrane. Bacteria are not susceptible to drug resistance through this antimicrobial mechanism. In this study, 28 short peptides containing 12 amino acid residues were designed based on nine amino acid fragments (KRIVQRIKD) from human cathelicidin LL-37, which is stable in gastric juice, and 3 amino acids were added at the C-terminus of the peptide. These designed peptides were not digested and degraded by pepsin at low pH values. The peptides were predicted using the online tool platform. Then, the strongest antimicrobial peptide, named SAMP-12aa (KRIVQRIKDVIR), was screened from 28 short peptides. Further studies found that SAMP-12aa retained anti-H. pylori activity after incubation in simulated gastric juice. The MIC and MBC of SAMP-12aa were 8 \u03bcg\/mL and 32 \u03bcg\/mL, respectively. SAMP-12aa showed good bactericidal kinetics. SAMP-12aa was found to have cell selectivity, penetrating and damaging bacterial cell membranes and exhibiting almost no toxicity to human cells at a relatively high concentration (128 \u03bcg\/mL). Regulatory T (Treg) cells express CD25High with immunosuppressive activity that induces immune tolerance in response to H. pylori. Molecular docking prediction revealed that SAMP-12aa could target the active center of Foxp3. Flow cytometry analysis revealed that SAMP-12aa can inhibit Foxp3 activity and downregulate CD25 protein expression on CD4+ T cells, thereby reducing the development and differentiation of CD4+Foxp3+CD25High Treg cells with immunosuppressive effects. Further research revealed that the levels of the cytokine interferon-\u03b3 (IFN-\u03b3), which activates CD8+ T-cell activity, were significantly elevated, and the levels of transforming growth factor-\u03b2 (TGF-\u03b2), which inhibits CD8+ T-cell activity, were significantly reduced. The results of this study reveal that SAMP-12aa not only possesses antibacterial activity but also has immunomodulatory effects.<\/jats:p>","DOI":"10.3390\/molecules31061002","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T09:35:57Z","timestamp":1773740157000},"page":"1002","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Design and Screening of the Peptide SAMP-12aa Derived from LL-37, Which Exhibits Anti-H. Pylori Activity and Immunomodulatory Effects"],"prefix":"10.3390","volume":"31","author":[{"given":"Jianliang","family":"Lu","sequence":"first","affiliation":[{"name":"The Department of Pharmacy, School of Biomedical and Health Sciences, Anhui Science and Technology University, Fengyang 233100, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyu","family":"Wang","sequence":"additional","affiliation":[{"name":"The Department of Pharmacy, School of Biomedical and Health Sciences, Anhui Science and Technology University, Fengyang 233100, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meisong","family":"Qin","sequence":"additional","affiliation":[{"name":"The Department of Pharmacy, School of Biomedical and Health Sciences, Anhui Science and Technology University, Fengyang 233100, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Dou","sequence":"additional","affiliation":[{"name":"The Department of Pharmacy, School of Biomedical and Health Sciences, Anhui Science and Technology University, Fengyang 233100, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyi","family":"Xiong","sequence":"additional","affiliation":[{"name":"The Department of Pharmacy, School of Biomedical and Health Sciences, Anhui Science and Technology University, Fengyang 233100, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4062-4697","authenticated-orcid":false,"given":"Xiaolin","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Department of Pharmacy, School of Biomedical and Health Sciences, Anhui Science and Technology University, Fengyang 233100, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.3748\/wjg.v30.i43.4636","article-title":"Prevalence of Helicobacter pylori infection in China from 2014\u20132023: A systematic review and meta-analysis","volume":"30","author":"Xie","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.gastro.2023.09.047","article-title":"Evolving Concepts in Helicobacter pylori Management","volume":"166","author":"Moss","year":"2024","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e22339","DOI":"10.1002\/jcla.22339","article-title":"Antibiotic resistance of H. pylori to 16 antibiotics in clinical patients","volume":"32","author":"Shao","year":"2017","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1007\/s00253-017-8302-9","article-title":"Fusion expression of the PGLa-AM1 with native structure and evaluation of its anti-H. pylori activity","volume":"101","author":"Zhang","year":"2017","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_5","first-page":"3972","article-title":"The Synthetic Antimicrobial Peptide Pexiganan and its Nanoparticles (PNPs) Exhibit the anti-H. pylori Activity in vitro and in vivo","volume":"20","author":"Zhang","year":"2015","journal-title":"Proteins"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/cei.13047","article-title":"Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease","volume":"191","author":"Kusaka","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1053\/j.gastro.2003.08.028","article-title":"Expression of LL-37 by Human Gastric Epithelial Cells as a Potential Host Defense Mechanism Against H. pylori","volume":"125","author":"Hase","year":"2003","journal-title":"Gastroenterology"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Leszczy\u0144ska, K., Namiot, A., Fein, D.E., Wen, Q., Namiot, Z., Savage, P.B., Scott, D.S., Janmey, P.A., and Bucki, R. (2009). Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against H. pylori in simulated gastric juice. BMC Microbiol., 9.","DOI":"10.1186\/1471-2180-9-187"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejmech.2017.05.028","article-title":"LL-37-derived short antimicrobial peptide KR-12-a5 and its D-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity","volume":"136","author":"Kim","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"32637","DOI":"10.1074\/jbc.M805533200","article-title":"Structures of human host defense cathelicidin LL-37 and its smallest anti-microbial peptide KR-12 in lipid micelles","volume":"283","author":"Wang","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.prp.2009.07.019","article-title":"The number of Foxp3-positive regulatory T cells is increased in Helicobacter pylori gastritis and gastric cancer","volume":"206","author":"Jang","year":"2010","journal-title":"Pathol. Res. Pract."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Engelsberger, V., Gerhard, M., and Mej\u00edas-Luque, R. (2024). Effects of Helicobacter pylori infection on intestinal microbiota, immunity and colorectal cancer risk. Front. Cell Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1339750"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e13138","DOI":"10.1111\/hel.13138","article-title":"Optimization of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Real-World Evidence Study","volume":"29","author":"Huang","year":"2024","journal-title":"Helicobacter"},{"key":"ref_14","first-page":"1093","article-title":"Role of regulatory T-cells in H. pylori-induced gastritis and gastric cancer","volume":"30","author":"Kandulski","year":"2010","journal-title":"Anticancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.femsim.2004.10.017","article-title":"CD4+CD25+ suppressor T cells regulate pathogen induced inflammation and disease","volume":"44","author":"Raghavan","year":"2005","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.0300-9475.2004.01447.x","article-title":"Antigen-specific in vitro suppression of murine Helicobacter pylori-reactive immunopathological T cells by CD4+CD25+ regulatory T cells","volume":"60","author":"Raghavan","year":"2004","journal-title":"Scand. J. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ding, H., Nedrud, J.G., Blanchard, T.G., Zagorski, B.M., Li, G., Shiu, J., Xu, J., and Czinn, S.J. (2013). Th1-mediated immunity against Helicobacter pylori can compensate for lack of Th17 cells and can protect mice in the absence of immunization. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0069384"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Nedrud, J.G., Czinn, S.J., Ding, H., Zagorski, B.M., Redline, R.W., Twaddell, W., and Blanchard, T.G. (2012). Lack of genetic influence on the innate inflammatory response to helicobacter infection of the gastric mucosa. Front. Immunol., 3.","DOI":"10.3389\/fimmu.2012.00181"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1128\/IAI.00553-07","article-title":"Expression of the programmed death ligand 1, B7-H1, on gastric epithelial cells after Helicobacter pylori exposure promotes development of CD4+ CD25+ FoxP3+ regulatory T cells","volume":"75","author":"Beswick","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1128\/IAI.73.1.523-531.2005","article-title":"Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients","volume":"73","author":"Lundgren","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/19490976.2015.1116673","article-title":"Systems-wide analyses of mucosal immune responses to Helicobacter pylori at the interface between pathogenicity and symbiosis","volume":"7","author":"Kronsteiner","year":"2016","journal-title":"Gut Microbes"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000508330","article-title":"The Protective Effects of Helicobacter pylori Infection on Allergic Asthma","volume":"182","author":"Zuo","year":"2021","journal-title":"Int. Arch. Allergy Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nri727","article-title":"The B7-CD28 superfamily","volume":"2","author":"Sharpe","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2174\/0929866524666170428150925","article-title":"Antimicrobial and Immunomodulatory Activity of PMAP-23 Derived Peptides","volume":"24","author":"Veldhuizen","year":"2017","journal-title":"Protein Pept. Lett."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.2174\/1381612824666180327165012","article-title":"Cryptic Antimicrobial Peptides: Identification Methods and Current Knowledge of their Immunomodulatory Properties","volume":"24","author":"Pizzo","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"16963","DOI":"10.1021\/bi991850y","article-title":"Structure and organization of hemolytic and nonhemolytic diastereomers of antimicrobial peptides in membranes","volume":"38","author":"Hong","year":"1999","journal-title":"Biochemistry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1080\/17512433.2019.1654858","article-title":"Multidrug Resistance in H. pylori: Current State and Future Directions","volume":"12","author":"Lyudmila","year":"2019","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41575-021-00449-x","article-title":"Helicobacter pylori infection and antibiotic resistance\u2014From biology to clinical implications","volume":"18","author":"Yamaoka","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/17474124.2018.1496017","article-title":"pylori drug resistance: Therapy changes and challenges","volume":"12","year":"2018","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/1040841X.2017.1418285","article-title":"Resistance mechanisms of H. pylori and its dual target precise therapy","volume":"44","author":"Gong","year":"2018","journal-title":"Crit. Rev. Microbiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijantimicag.2008.04.003","article-title":"Design and synthesis of cationic antimicrobial peptides with improved activity and selectivity against Vibrio spp","volume":"32","author":"Chou","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1042\/bj3410501","article-title":"Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: Relevance to the molecular basis for its noncell-selective activity","volume":"341","author":"Oren","year":"1999","journal-title":"Biochem. J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4049\/jimmunol.167.3.1245","article-title":"CD4+CD25high regulatory cells in human peripheral blood","volume":"167","author":"Brown","year":"2001","journal-title":"J. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"12316","DOI":"10.1074\/jbc.M413406200","article-title":"Rationaldesign of alpha-helical antimicrobial peptides with enhanced activities and specificity\/therapeutic index","volume":"280","author":"Chen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/bip.20660","article-title":"Biological and structural characterization of new linear gomesin analogues withimproved therapeutic indices","volume":"88","author":"Fazio","year":"2007","journal-title":"Biopolymers"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.bbamem.2010.06.026","article-title":"Structural flexibility and the positive charges are the key factors in bacterial cell selectivity and membrane penetration of peptoid-substituted analog of Piscidin 1","volume":"1798","author":"Kim","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.peptides.2010.03.032","article-title":"Cell selectivity and anti-inflammatoryactivity of a Leu\/Lys-rich alpha-helical model antimicrobial peptideand its diastereomeric peptides","volume":"31","author":"Wang","year":"2010","journal-title":"Peptides"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","article-title":"Computational approaches streamlining drug discovery","volume":"616","author":"Sadybekov","year":"2023","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Pinzi, L., and Rastelli, G. (2019). Molecular Docking: Shifting Paradigms in Drug Discovery. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20184331"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/bib\/bbp023","article-title":"Recent advances in computer-aided drug design","volume":"10","author":"Song","year":"2009","journal-title":"Brief. Bioinform."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s12272-015-0640-5","article-title":"Role of computer-aided drug design in modern drug discovery","volume":"38","author":"Macalino","year":"2015","journal-title":"Arch. Pharm. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1126\/science.1096361","article-title":"The Many Roles of Computation in Drug Discovery","volume":"303","author":"Jorgensen","year":"2004","journal-title":"Science"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1128\/IAI.00524-10","article-title":"Invasion and multiplication of Helicobacter pylori in gastric epithelial cells and implications for antibiotic resistance","volume":"78","author":"Chu","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1128\/IAI.00660-13","article-title":"Helicobacter pylori infection in a pig model is dominated by Th1 and cytotoxic CD8+ T cell responses","volume":"81","author":"Kronsteiner","year":"2013","journal-title":"Infect. Immun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.semcdb.2020.01.007","article-title":"Cellular evasion strategies of Helicobacter pylori in regulating its intracellular fate","volume":"101","author":"Sit","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1365-2672.2000.00971.x","article-title":"Fluorometric assessment of gram-negative bacterial permeabilization","volume":"88","author":"Helander","year":"2000","journal-title":"J. Appl. Microbiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/AAC.26.4.546","article-title":"Use of the fluorescent probe 1-N-Phenylnaphthyl-amine to study the interactions of aminoglycoside antibiotics with the outer membrane of pseudomonas aeruginosa","volume":"26","author":"Loh","year":"1984","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/AAC.46.3.689-694.2002","article-title":"Antibacterial properties of dermaseptin S4 derivatives with in vivo activity","volume":"46","author":"Feder","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.peptides.2012.04.004","article-title":"Prokaryotic Selectivity and LPS-neutralizing Activity of Short Antimicrobial Peptides Designed From the Human Antimicrobial Peptide LL-37","volume":"35","author":"Yong","year":"2012","journal-title":"Peptides"},{"key":"ref_52","first-page":"57","article-title":"Python: A programming language for software integration and development","volume":"17","author":"Sanner","year":"1999","journal-title":"J. Mol. Graph. Model."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/6\/1002\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:16:11Z","timestamp":1773897371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/6\/1002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["molecules31061002"],"URL":"https:\/\/doi.org\/10.3390\/molecules31061002","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]}}}